Clinical characteristics of cerebral cryptococcosis in HIV-infected patients: Hospital Nacional de Paraguay years 2012 to 2020

Main Article Content

Alba Concepción Aveiro
https://orcid.org/0000-0003-4525-9019
Vanesa Aniana Fretes Lezcano
https://orcid.org/0000-0002-2515-3287
Raúl Emilio Real Delor
https://orcid.org/0000-0002-5288-5854
Martha Rosa Lourdes Marín Ricart

Abstract

Introduction: the clinical picture of HIV infection reflects the progressive immunodeficiency from the initial phases, sometimes asymptomatic to the final, when clinically it corresponds to more advanced stages of immunosuppression, with CD4 T lymphocytes <100cells / μL, the acquired immunodeficiency syndrome, in the one that already appears the defining diseases, one of them the cerebral cryptococcosis.
Objectives: to describe the clinical characteristics of cerebral cryptococcosis in HIV-infected patients admitted to the Medical Clinic Service of the Hospital Nacional - Itauguá, Paraguay from 2012 to 2020.
Methodology: a descriptive, retrospective, cross-sectional observational study was carried out in patients of both sexes older than 18 years.
Results: 35 patients were studied, 69 % were male, with a median age of 43 years. 100 % were without antiretroviral treatment upon admission, 74 % were not known to be infected with HIV, and 26 % had no adherence to treatment. The evolutionary picture on average was 20 days (2 to 90 days), 91 % of the symptoms on admission were neurological, the predominant being headache, which occurred in isolation in 28% and the rest with another neurological symptom . The mean viral load was 867,464 copies / mL, the median CD4 level was 34 cells / mm3 and 100 % <150 cells / mm3. The mean cerebrospinal fluid findings were glucorrhachia 37 mg / dl, protein sprain 174 mg / dl, cellularity 46 % ≤ 6 cells / μl, 98% predominantly mononuclear. All were treated with amphotericin B and maintenance with fluconazole. The median number of days of hospitalization was 30 days and mortality was 26 %, with poor prognosis factors being: late consultation, unknown HIV-infected patients, and higher viral load.
Conclusions: most of the cases could be evidenced in male patients, young adults, in the AIDS stage, 100 % without antiretroviral treatment, and late consultation and high viral load as poor prognostic factors. The suspicion of meningeal cryptococcosis-HIV concomitance is valid in patients with chronic headache even in unknown patients infected with HIV.

Article Details

How to Cite
1.
Aveiro AC, Fretes Lezcano VA, Real Delor RE, Marín Ricart MRL. Clinical characteristics of cerebral cryptococcosis in HIV-infected patients: : Hospital Nacional de Paraguay years 2012 to 2020. Rev. Nac. (Itauguá) [Internet]. 2021 Jul. 15 [cited 2025 Jan. 18];13(1):76-87. Available from: https://revistadelnacional.com.py/index.php/inicio/article/view/41
Section
Artículo Original

References

Mandell GL, Bennett JE, Dolin R. Enfermedades infecciosas: principios y prácticas. 8a. ed. Vol. 2. Elsevier: Barcelona. p. 3101-3105.

Sardiñas Ponce R. Actualización sobre el virus de inmunodeficiencia humana y el síndrome de inmunodeficiencia adquirida Revista Electrónica de las Ciencias Médicas en Cienfuegos. 2010;8(3):33-39. Disponible en: http://scielo.sld.cu/pdf/ms/v8n3/v8n3a790.pdf

Tobón Pereira JC, Toro Montoya AI. Estudio del paciente con infección por VIH. Med Lab. 2008;14(01–02):11–42

Cachay ER. Infección por el virus de inmunodeficiencia humana (HIV). 2019. Disponible en: https://www.msdmanuals.com/es/professional/enfermedades-infecciosas/virus-de- inmunodeficiencia-humana-hiv/infecci%C3%B3n-por-el-virus-de-inmunodeficiencia-humana-hiv.

Ramírez Sergio, Roa Luis, Triana Javier, Marín Jorge, Clavijo-Prado Carlos, Cárdenas Karem et al . Criptococosis cerebral: descripción de una serie de casos con presentaciones típicas y atípicas en el Hospital Universitario San José Infantil de Bogotá. Acta Neurol Colomb. [Internet]. 2015 Apr [cited 2021 Apr 11] ; 31( 2 ): 158-166. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-

Danger H, Salinas R. Infecciones del sistema nervioso central en pacientes con SIDA. Hospital Distrital " Pholosong ”. Johannesburgo . Sudáfrica . 2018. Disponible en: file:///C:/Users/EMIBAU~1/AppData/Local/Temp/2128-4755-1-PB.pdf

Díaz JH. The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections Wilderness &Environ Med. 2020;31(1): 101-109. doi: 10.1016/j.wem.2019.10.004.

Lizarazo J, Linares M, De Bedout C, Restrepo Á, Agudelo CI, Castañeda E, et al. Estudio clínico y epidemiológico de la criptococosis en Colombia: resultados de nueve años de la encuesta nacional, 1997-2005. Biomédica. 2007;27(1):94.

Duque Díaz H. Criptococosis meníngea y pulmonar por c. Gattii en un paciente inmunocompetente. Rev ArgMed. 2020;8(2): 138-141. http://www.revistasam.com.ar/index.php/RAM/article/view/430

Makadzange AT, McHugh G. New approaches to the diagnosis and treatment of cryptococcal meningitis. Semin Neurol. 2014;34(1):47-60. doi: 10.1055/s-0034-1372342. Epub 2014 Apr 8. PMID: 24715488.

Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS. 2007; 18;21(16):2119-29. doi: 10.1097/QAD.0b013e3282a4a64d.

Firacative C, Lizarazo J, Illnait-Zaragozí MT, Castañeda E, Arechavala A, Córdoba S, et al. The status of cryptococcosis in latin America. Mem Inst Oswaldo Cruz. 2018;113(7):1–23.

Messina FA, Maiolo E, Negroni R, Arechavala A, Santiso G, Bianchi M. Alternativas terapéuticas de la criptococosis meníngea. actualizaciones en sida e infectología. Buenos Aires. 2015;23(88):25–32.

Sicer M. Criptococosis meningea en pacientes infectados por el VIH. Clinica-UnrComAr [Internet]. 2012; Disponible en: http://www.clinica-unr.com.ar/Posgrado/trabajos-graduados/maxi_sicer.pdf

Sierra Saldívar A. Meningitis criptocóccica Cryptococcal meningitis. Rev Nac. 2013;5(1):34–43.

Castañeda E, Lizarazo J. Protocolo de estudio y manejo de los pacientes con criptococosis A protocol for the study and management of patients with cryptococcosis Infectio Asociación Colombiana de Infectología. Infectio. 2012;16(3):123–5.

Sloan DJ, Parris V. Cryptococcal meningitis: Epidemiology and therapeutic options. Clin Epidemiol. 2014;6(1):169–82.

Gómez Árias B, Zarco Montero LA. Meningeal criptococcosis: clinical and laboratory characteristics. Acta Neurol Colomb. 2011;27(1):9–27.

Patel AK, Patel KK, Ranjan R, Shah S, Patel JK. Management of cryptococcal meningitis in HIV-infected patients: Experience from western India. Indian J Sex Transm Dis. 2010;31(1):22–6.

Sloan DJ, Parris V. Meningitis criptocócica: epidemiología y opciones terapéuticas, Clin Epidemiol. 2014; 6: 169-182. doi: 10.2147 / CLEP.S38850.

Cangelosi D, De Carolis L, Trombetta L, Wainstein C. Criptococosis meníngea asociada al SIDA. Análisis de los pacientes varones HIV (+) con criptococosis meníngea internados en la Sala 11 del Hospital Francisco J Muñiz. Rev Asoc Med Argent. 2009;122(3):25–30.

Concha-Velasco F, González-Lagos E, Seas C, Bustamante B. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis. PLoS One. 2017;12(3):1–12.